Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in: BMC Anesthesiology 1/2018

Open Access 01-12-2018 | Research article

The effects of Desflurane and Sevoflurane on Nesfatin-1 levels in laparoscopic Cholecystectomy: a randomized controlled trial

Authors: A. T. D. Ozcan, C. B. Altin, S. Erdogan, M. Ergin, A. Çiftçi, H. Kara, S. M. Aksoy, A. But

Published in: BMC Anesthesiology | Issue 1/2018

Login to get access

Abstract

Background

Nesfatin-1 is involved in cardiovascular regulation, stress-related responses. The objective of this study is to investigate the impact of volatile anesthetics on Nesfatin-1 levels.

Method

Fourty-two patients aged 30–65 years with the American Society Anesthesiology (ASA) Class I-II who were scheduled for laparoscopic cholecystectomy were included in the study Patients were randomized into two group; desflurane administered group (Group I, n = 21) and sevoflurane administered group (Group II, n = 21). For anesthesia maintenance, the patients received 6% desflurane or 2% sevoflurane in 40% O2 and 60% air. The patient’s heart rate (HR), mean, systolic and diastolic arterial pressures (MAP, SAP, DAP), peripheral O2 saturation (SpO2) were monitored and recorded before induction, after induction, after intubation, and during extubation. Blood samples were collected before induction (T1), and after extubation when aldrete score was 10 (T2).

Results

Demographic data were similar between the groups. The preoperative levels of nesfatin were similar in the two groups (p = 0.715). In desflurane group, post-operative nesfatin levels were similar compared to preoperative levels (p = 0.073). In sevoflurane group, post-operative nesfatin levels were similar (p = 0.131). The nesfatin levels (postoperative vs preoperative) were similar between the groups (p = 0.900).

Conclusion

In conclusion, this study results suggest that nesfatin-1 levels are not affected by the use of sevoflurane or desflurane in patients undergoing laparoscopic cholecystectomy.

Trial registration

Australian New Zealand Clinical Trials Registry, ACTRN12617001023​347, retrospectively registered on 17 July 2017.
Literature
1.
Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709–12.CrossRefPubMed
2.
Hofmann T, Stengel A, Ahnis A, Busse P, Elbelt U, Klapp BF. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients. Psychoneuroendocrinology. 2013;38:2502–10.CrossRefPubMed
3.
Goebel M, Stengel A, Wang L, Lambrecht NW. Tache´ Y. Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci Lett. 2009;452:241–6.CrossRefPubMedPubMedCentral
4.
Stengel A, Goebel M, Wang L, Taché Y. Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats. Peptides. 2010;31:263–70.CrossRefPubMed
5.
Bonnet MS, Djelloul M, Tillement V, Tardivel C, Mounien L, Trouslard J, Troadec J-D, Dallaporta M. Central NUCB2/Nesfatin-1-expressing Neurones belong to the hypothalamic-brainstem circuitry activated by Hypoglycaemia. J Neuroendocrinol. 2013;25:1–13.CrossRefPubMed
6.
Feijoo-Bandin S, Rodriguez-Penas D, Garcia-Rua V, Mosquera-Leal A, Otero MF, Pereira E, Rubio J, Martinez I, Seoane LM, Gualillo O, et al. Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of Glut-4. Endocrinology. 2013;154:4757–67.CrossRefPubMed
7.
Pałasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz R, Bajor G. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides. 2012;46:105–12.CrossRefPubMed
8.
Naito Y, Fukata J, Tamai S, Seo N, Nakai Y, Mori K, et al. Biphasic changes in hypothalamopituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab. 1991;73:111–7.CrossRefPubMed
9.
Goebel M, Stengel A, Wang L, Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain. 2009;1300:114–24.CrossRef
10.
Xu L, Bloem B, Gaszner B, Roubos EW, Kozicz T. Stress related changes in the activity of cocaine- and amphetamine regulated transcript and nesfatin neurons in the midbrain nonpreganglionic Edinger-Westphal nucleus in the rat. Neuroscience. 2010;170:478–88.CrossRefPubMed
11.
Yoshida N, Maejima Y, Sedbazar U, Ando A, Kurita H, Damdindorj B, Takano E, et al. Stressor responsive central nesfatin-1 activates corticotropin releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic pituitary adrenal axis. Aging. 2010;2:774–8.CrossRef
12.
Marana E, Russo A, Colicci S, Polidori L, Bevilacqua F, Viviani D, Di Stasio E. Desflurane versus sevoflurane: a comparison on stress response. Minerva Anestesiol. 2013 Jan;79(1):7–14.PubMed
13.
Şimşek T, Şimşek HU, Cantürk NZ. Response to trauma and metabolic changes: posttraumatic metabolism. Ulus Cerrahi Derg. 2014;30(3):153–9.PubMedPubMedCentral
14.
Tanida M, Mori M. Nesfatin-1 stimulates renal sympathetic nerve activity in rats. Neuroreport. 2011;22:309–12.CrossRefPubMed
15.
Feijo’o-Bandı’n S, Rodrı’guez-Penas D, Garcı’a-Ru’a V, Jose’A M-L, Gonza’lez-Juanatey R, Lago F. Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level Endocrine. 2016;52:11–29.
16.
Garcı’a-Galiano D, Navarro VM, Gaytan F, Tena-Sempere M. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol. 2010;45:281–90.CrossRef
17.
Ding S, Qu W, Dang S, Xie X, Xu J, Wang Y, Jing A, Zhang C, Wang J. Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheralarterial disease. Med Sci Monit. 2015;21:987–91.CrossRefPubMedPubMedCentral
18.
Shen P, Han Y, Cai B, Wang Y. Decreased levels of serum nesfatin-1 inpatients with obstructive sleep apnea syndrome. Sleep Breath. 2015;19:515–22.CrossRefPubMed
19.
Sahin FK, Sahin SB, Ural UM, Cure MC, Senturk S, Tekin YB, Balik G, Cure E, Yuce S, Kirbas A. Nesfatin-1 and vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. Bosn J Basic Med Sci. 2015 Jul 9;15(3):57–63.PubMedPubMedCentral
20.
Araz O, Yilmazel UE, Dorman E, Bayraktutan Z, Yayla M, Yilmaz N, Acemoglu H, Halici Z, Akgun M. Is there a relationship between obstructive sleep apnea syndrome severity and nesfatin-1? Respiration. 2015;90:105–10.CrossRefPubMed
21.
Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology. 2008;201:115–23.CrossRefPubMed
22.
Ge JF, Xu YY, Qin G, Pan XY, Cheng JQ, Chen FH. Nesfatin-1, a potent anorexic agent, decreases exploration and induces anxiety-like behavior in rats without altering learning or memory. Brain Res. 1629;2015:171–81.
23.
Emmerzaal TL, Kozicz T. Nesfatin-1: implication in stress and stress-associated anxiety and depression. Curr Pharm. 2013;19:6941–8.CrossRef
24.
Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008;156:563–79.CrossRefPubMed
25.
Dogan U, Bulbuller N, Cakır T, Habibi M, Mayir B, Koc U, Aslaner A, Ellidag HY, Gomceli I. Nesfatin-1 hormone levels in morbidly obese patients after l laparoscopic sleeve gastrectomy. Eur Rev Med Pharmacol Sci. 2016;20(6):1023–31.PubMed
26.
Hofmann T, Elbelt U, Ahnis A, Rose M, Klapp BF, Stengel A. Sex-specificregulation of NUCB2/nesfatin-1: differential implication in anxiety in obesemen and women. Psychoneuroendocrinology. 2015;60:130–7.CrossRefPubMed
27.
Goebel-Stengel M, Stengel A. Role of brain NUCB2/nesfatin-1 in thestress-induced modulation of gastrointestinal functions. CurrNeuropharmacol. 2016;14:882–91.
28.
Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol. 2010 Oct;73(4):484–90.
29.
Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama K, Amitani M, Harada T, Yasuhara D, Inui A. Plasma nesfatin-1 concentrationsin restricting-type anorexia nervosa. Peptides. 2011;32:150–3.CrossRefPubMed
30.
Hofmann T, Ahnis A, Elbelt U, Rose M, Klapp BF, Stengel A. NUCB2/nesfatin-1 is associated with elevated levels of anxiety in anorexia nervosa. PLoS One. 2015;10(7):e0132058.CrossRefPubMedPubMedCentral
31.
Britton KT, Segal DS, Kuczenski R, Hauger R. Dissociation between in vivo hippocampal norepinephrine response and behavioral/neuroendocrine responses to noise stress in rats. Brain Res. 1992;574:125–30.CrossRefPubMed
32.
Bonaz B, Taché Y. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res. 1994;641:21–8.CrossRefPubMed
33.
Campeau S, Watson SJ. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J Neuroendocrinol. 1997 Aug;9(8):577–88.PubMed
34.
Ishida Y, Hashiguchi H, Takeda R, Ishizuka Y, Mitsuyama Y, Kannan H, et al. Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse. 2002;45:46–51.CrossRefPubMed
35.
Stengel A, Taché Y. Nesfatin-1 - role as possible new potent regulator of food intake. Regul Pept. 2010;9:18–23.CrossRef
Metadata
Title
The effects of Desflurane and Sevoflurane on Nesfatin-1 levels in laparoscopic Cholecystectomy: a randomized controlled trial
Authors
A. T. D. Ozcan
C. B. Altin
S. Erdogan
M. Ergin
A. Çiftçi
H. Kara
S. M. Aksoy
A. But
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2018
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-018-0484-x

Other articles of this Issue 1/2018

BMC Anesthesiology 1/2018 Go to the issue

Research article

The predictive value of hunger score on gastric evacuation after oral intake of carbohydrate solution

Research article

Early postoperative recovery in operating room after desflurane anesthesia combined with Bispectral index (BIS) monitoring and warming in lengthy abdominal surgery: a randomized controlled study

Research article

Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials

Research article

Experiences of ICU survivors in a low middle income country- a multicenter study

Research article

Respiratory variation in peripheral arterial blood flow peak velocity to predict fluid responsiveness in mechanically ventilated patients: a systematic review and meta-analysis

Research article

Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17 and regulatory T cells cytokine levels and their balance: a prospective, randomised, double-blind, dose-response clinical study